Health Professional Radio - Podcast

Dr. Tracy Frech, a rheumatologist from the University of Utah discusses her work with Corbus Pharmaceuticals to address systemic sclerosis (SSc) through a disease state education program with a new website geared towards physicians. The program will provide resources to better equip them for treating their patients and understanding the need to address the totality of SSc, a rare, complex and debilitating disease.

Dr. Bruce Clark, CEO of Medicago, a biopharmaceutical company headquartered in Quebec City, and a leader in plant-based technology, discusses the announcement on March 12, 2020 that they had successfully produced a Virus-Like Particle (VLP) of the coronavirus just 20 days after obtaining the SARS-CoV-2 (virus causing the COVID-19 disease) gene using plant-based technology. Production of the VLP is the first step in developing a vaccine for COVID-19, which will now undergo preclinical testing for safety and efficacy. Once this is completed, Medicago expects to discuss with the appropriate Health Agencies to initiate human trials of the vaccine by summer (July/August) 2020.

Rebecca Kasen, advocacy director at Community Access Unlimited (CAU) in New Jersey discusses what the month of March as Developmental Disability Awareness Month means to them and the many programs available to assist people. CAU assists with housing, life skills, employment, money management, socialization, civic activities, and so much more.

Dr. Jacqueline Jones, MD, one of America's Top Doctors™, discusses concerns about coronavirus from the parent/child perspective and her latest book "Medical Parenting: How to Navigate Health, Wellness & The Medical System with Your Child".

Dr. Payam Shakouri, a nephrologist, discusses uncontrolled gout and its connection to chronic kidney disease (CKD). Approximately 1 in 4 adults with CKD has gout. It’s 10x more likely for a person with moderate-to-severe CKD to have gout than someone who does not.

Adam Cogar, a kidney transplant recipient, talks about his 15-year journey to a diagnosis of uncontrolled gout. He discusses how the pain had impacted his daily life and how different his life is now that he has a clear diagnosis, treatment plan in place, and can manage his condition. The prevalence of gout is more than ten-fold greater among patients who have undergone a kidney transplant than the general population.

Incyte, a global biopharmaceutical company announces its opening call for submissions for its new Incyte Ingenuity Award. a program created to support people living with graft-versus-host disease (GVHD), as well as their caregivers and physicians. GVHD is a potentially life-threatening condition that can occur after a stem cell or bone marrow transplant from a donor initiate an immune response and attack the transplant recipient's organs. Here to talk about Incyte's dedication to the program is Incyte's Executive Vice President, General Manager, United States, Dr. Barry Flannelly. The program is expected to fund up to $100,000 a year for one innovative program or idea.

Kyle Silvestro, CEO of the healthcare software company SyTrue, Inc., discusses SyTrue's Natural Language Processing (NLP) Operating System (OS) NLP OS™ and how they are offering their services for free for COVID-19 studies. He also talks about SyTrue's partnering with Microsoft.

Dr. Bettina Cockroft, M.D., SVP and CMO at Sangamo Therapeutics, Inc., a gene therapy company, discusses their approach to treating disease and why genomic medicines are so important to the future of medicine. She also talks about one of the latest therapies Sangamo has in a Phase 1/2 clinical trial for the treatment of Fabry disease, a rare, X-linked lysosomal storage disorder caused by a gene mutation in an enzyme responsible for breaking down fatty substances.

Dr. Ankit Shah, a leading cardiologist with MedStar Health in Baltimore, MD, discusses a promising new tool, an interactive heart risk calculator that will help patients get a quicker and more personal assessment of their risk for heart disease, stroke, and other cardiovascular diseases. MedStar Health patients for the first time will see their heart health information embedded in their electronic health records (EHRs) using an easy-to-read, interactive interface. It will quickly show patients the impact that their current blood pressure, cholesterol and other risk factors play in their risk of heart disease or stroke.

The Gloucester Marine Genomics Institute (GMGI) in Gloucester, Massachusetts has recently received Workforce Skills Capital Grants to expand its facilities and purchase biomanufacturing equipment in order to train an even bigger group of Academy students for careers in biotechnology, an industry that is desperate for talent / trained professionals. Here to talk about this news and the future of training top biotechnology workers to meet the industry’s ever-growing demand is Chief Operating Officer Chris Bolzan.

Michelle Dickinson, Author, TED Speaker, and advocate, discusses ways to decrease the mental health stigma and shame that prevents people from accessing care, why we should invest in mental health or brain health in the workplace and her own personal story of perseverance and triumph.

Returning guest, Dr. Gregg Sylvester, Chief Medical Officer at Seqirus discusses the background on the new formulation of FLUAD® QUADRIVALENT, the first and only adjuvanted quadrivalent influenza vaccine, and its importance. It was developed to help protect adults 65 years and older against seasonal influenza.

Dr. Asit Parikh, MD, SVP, and head of the Gastrointestinal Therapeutic Area at Takeda Pharmaceutical Company Limited discusses new data presented at the 15th Congress of the European Crohn’s and Colitis Organisation (ECCO) from the phase 3 VISIBLE 2 clinical trial evaluating the efficacy and safety of an investigational subcutaneous (SC) formulation of vedolizumab (Entyvio®) for use during maintenance therapy in adult patients with moderately to severely active Crohn's disease (CD).

Dr. Paul Limburg, a gastroenterology consultant at the Mayo Clinic, and CMO for screening at Exact Sciences, and co-author of this study discusses the results of the colorectal cancer screening study published in the Journal of Medical Screening. The study indicated high adherence to getting screened with the at-home, stool-based, multi-target DNA test. These findings point to the importance of choice in colorectal cancer (CRC) screening options, as well as the role of patient navigation programs to help with adherence, at a time when 1-in-3 individuals are not up to date on CRC screening.

Jeff Chilton, owner, and founder of Nammex Organic Mushrooms Extracts discusses mushrooms as medicine and their amazing health benefits. Jeff is also the author of the book titled "The Mushroom Cultivator".

Darcy Klug, CEO and Chairman of Redhawk Holdings Corp. discusses the SANDD mini–First Responder™ a portable battery-operated sharps and needle destruction device that uses electricity to heat and incinerate needles in seconds leaving no sharp portions. He also talks about why these devices should be in every hospital, nurse's office and homeless shelter throughout the country and the success that has been seen in Louisiana.

Kati Morton, Licensed Marriage and Family Therapist (LMFT) and author of "Are U Ok?: A Guide to Caring for Your Mental Health" discusses social media and the effect it can have on mental health.

Dr. Raymond Douglas, an oculoplastic surgeon, discusses the approval of TEPEZZA™ (teprotumumab-trbw) for the treatment of Thyroid Eye Disease (TED), the first and only FDA-approved medicine for the treatment of TED. The FDA approval of TEPEZZA™ is supported by a robust body of clinical evidence, including statistically significant, positive results from the Phase 2 clinical study, as well as the Phase 3 confirmatory clinical study OPTIC. Dr. Douglas previously presented at the American College of Rheumatology (ACR) 2019 annual meeting, sharing integrated, pooled phase 2/phase 3 clinical study data that further substantiates that teprotumumab improves the debilitating effects of active TED, including proptosis (eye bulging), diplopia (double vision), quality of life (QoL) and clinical activity score (CAS). He is joined by Wendy a participant in the TEPEZZA™ trial who saw an improvement in her eye bulging among other symptoms.

Dr. Angela Nicholas, M.D., a Fight Colorectal Cancer board member, and advocate discusses new guidelines from the American Cancer Society that has recommended screening as early as age 45 due to evidence of an increase in colorectal cancer in those under 50, and available screening tests which include a noninvasive at-home option called Cologuard for those at average risk. She also shares her own personal journey with her husband who was diagnosed with stage IV colorectal cancer.